Correction: Strategies for Combination Therapy to Address Resistance to Immune Checkpoint Inhibitors - Top-Institutions - MDSpire

Correction: Strategies for Combination Therapy to Address Resistance to Immune Checkpoint Inhibitors

  • By

  • Besan H. Alsaafeen

  • Bassam R. Ali

  • Eyad Elkord

  • April 24, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Immuno-oncology
    • Medical Oncology
    • Translational Research

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Immuno-oncology
    • Medical Oncology
    • Cancer Immunotherapy

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Immuno-oncology
    • Hematology-Oncology
    • Cancer Biology

  • #4

    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

    Baltimore, MD

    Key Differentiators

    • Immuno-oncology
    • Medical Oncology
    • Cancer Immunotherapy

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Immuno-oncology
    • Medical Oncology
    • Translational Medicine

Original Source(s)

Correction: Strategies for Combination Therapy to Address Resistance to Immune Checkpoint Inhibitors

  • by Besan H. Alsaafeen, Bassam R. Ali, Eyad Elkord

  • April 24, 2026

Related Content

Editorial: Overcoming resistance to immune checkpoint inhibitors: mechanisms and strategies in cancer therapy

Artificial intelligence-assisted double reading of chest radiographs to detect clinically relevant missed findings: a two-centre evaluation

Determining the threshold time in restricted mean survival time analysis for two group comparisons with applications in clinical and epidemiology studies